Orthotolidine

Orthotolidine

SCHEMBL3466480

Cc1cc(-c2ccc(N)c(C)c2)ccc1N.Cl

nearest known ligand 0.94

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Orthotolidine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 10/20 0.94
TDP1 Q9NUW8 9/20 0.94
ALDH1A1 P00352 9/20 0.94
TSHR P16473 5/20 0.94
MEN1 O00255 2/20 0.52
KMT2A Q03164 2/20 0.52
MAPK1 P28482 3/20 0.50
HSD17B10 Q99714 4/20 0.46
ALOX15 P16050 3/20 0.46
SMN1; SMN2 Q16637 3/20 0.46
NPC1 O15118 2/20 0.46
RAB9A P51151 2/20 0.46
KDM4E B2RXH2 2/20 0.46
MAPT P10636 2/20 0.46
PKM P14618 1/20 0.46
TP53 P04637 3/20 0.46
S100B P04271 1/20 0.45
SKP2 Q13309 1/20 0.43
APP P05067 1/20 0.43
HPGD P15428 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Orthotolidine SCHEMBL867121 1.00 CYP3A4 (0.94) CYP3A4TDP1ALDH1A1TSHRMEN1
Orthotolidine SCHEMBL38664709 1.00 CYP3A4 (0.94) CYP3A4TDP1ALDH1A1TSHRMEN1
Orthotolidine SCHEMBL864763 0.97 CYP3A4 (0.90) CYP3A4TDP1ALDH1A1TSHRMEN1
Orthotolidine SCHEMBL29386552 0.97 CYP3A4 (1.00) CYP3A4TDP1ALDH1A1TSHRMEN1
Orthotolidine SCHEMBL49414 0.97 CYP3A4 (1.00) CYP3A4TDP1ALDH1A1TSHRMEN1
Orthotolidine SCHEMBL29365329 0.97 CYP3A4 (1.00) CYP3A4TDP1ALDH1A1TSHRMEN1
Orthotolidine SCHEMBL11189493 0.94 CYP3A4 (0.94) CYP3A4TDP1ALDH1A1TSHRMEN1
SCHEMBL8954009 0.94 CYP3A4 (0.94) CYP3A4TDP1ALDH1A1TSHRMEN1
Orthotolidine SCHEMBL20547383 0.94 CYP3A4 (0.94) CYP3A4TDP1ALDH1A1TSHRMEN1
Orthotolidine SCHEMBL22129692 0.94 CYP3A4 (0.94) CYP3A4TDP1ALDH1A1TSHRMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 67 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103170083-A Fire extinguishing composition containing transition metal compound SHAANXI J & R FIRE FIGHTING CO 2013-06-26 CN claimed
EP-0918881-B1 DRY REAGENT TEST STRIP COMPRISING BENZIDINE DYE PRECURSOR AND ANTIPYRINE COMPOUND AMIRA MEDICAL (US) 2004-02-11 EP claimed
US-5824491-A OXIDASE ENZYME AS ANALYTE ON SUBSTRATE, FORMING PEROXIDE, BENZIDINE DYE PRECURSOR, PEROXIDASE ENZYME WITH ANTIPYRENE COMPOUND MERCURY DIAGNOSTICS, INC. (US) 1998-10-20 US claimed
US-4129417-A Multisystem test means MILES LABORATORIES, INC. (US) 1978-12-12 US claimed
CN-106662573-B For determining the container of urinary precipitation in analyte and/or chemico-physical parameter and determining urine in urine;And the method for using the container carrying out full urinalysis 赛克利普有限公司 2019-10-11 CN disclosed
EP-3155421-B1 CONTAINER FOR DETERMINING OF ANALYTES AND/OR CHEMICO-PHYSICAL PARAMETERS, AS WELL AS DETERMINING OF URINARY SEDIMENT, IN URINE; AND METHOD OF FULL URINE ANALYSIS USING THIS CONTAINER SIKELIUP S R L (IT) 2019-02-20 EP disclosed
US-20180202992-A1 CONTAINER FOR DETERMINING OF ANALYTES AND/OR CHEMICO-PHYSICAL PARAMETERS, AS WELL AS DETERMINING OF URINARY SEDIMENT, IN URINE; AND METHOD OF FULL URINE ANALYSIS USING THIS CONTAINER SIKELIUP S.R.L. (IT) 2018-07-19 US disclosed
US-9949671-B2 Diagnostic mouthpieces ORTHOACCEL TECHNOLOGIES, INC. (US) 2018-04-24 US disclosed
US-20170181675-A9 DIAGNOSTIC MOUTHPIECES ORTHOACCEL HOLDINGS, LLC 2017-06-29 US disclosed
CN-106662573-A Container for determining of analytes and/or chemico-physical parameters, as well as determining of urinary sediment, in urine; and method of full urine analysis using this container 赛克利普有限公司 2017-05-10 CN disclosed
EP-3155421-A1 CONTAINER FOR DETERMINING OF ANALYTES AND/OR CHEMICO-PHYSICAL PARAMETERS, AS WELL AS DETERMINING OF URINARY SEDIMENT, IN URINE; AND METHOD OF FULL URINE ANALYSIS USING THIS CONTAINER Sikeliup S.r.l. (IT) 2017-04-19 EP disclosed
CN-103170083-B Fire extinguishing composition containing transition metal compound XI'AN J & R FIRE FIGHTING EQUIPMENT Co.,Ltd. (CN) 2016-04-06 CN disclosed
EP-0444263-A1 Improved composition, device and method of assaying for peroxidatively active substances Bayer Corporation (US) 1991-09-04 EP disclosed
EP-0299044-A4 DRY REAGENT DELIVERY SYSTEM 1991-01-16 EP disclosed
EP-0299044-A1 DRY REAGENT DELIVERY SYSTEM TECHNIMED CORPORATION (US) 1989-01-18 EP disclosed
US-4774192-A A dry reagent delivery system with membrane having porosity gradient TECHNIMED CORPORATION (US) 1988-09-27 US disclosed
WO-1988005912-A1 DRY REAGENT DELIVERY SYSTEM TECHNIMED CORPORATION (US) 1988-08-11 WO disclosed
US-4373087-A P-PHENYLENEDIAMINE, TEREPHTHALIC ACID UBE INDUSTRIES LTD. (JP) 1983-02-08 US disclosed
US-4153512-A PROPAGATING MICROORGANISMS USING GRADUATED CONCENTRATION SERIES, POLYBINYLPYRROLIDONE BULKING AGENT FISHER SCIENTIFIC COMPANY (US) 1979-05-08 US disclosed
US-4017261-A Biological diagnostic test strip and method of producing same LACHEMA, NARODNI PODNIK (CS) 1977-04-12 US disclosed